Japan followed the EU EMA rejection? Stockvadar-unplugs
Investors need to read Arena's 10K to see that Eisai is obligated to "talk" to Japan about Belviq AFTER it first talks with the EU. This FLATLY IMPLIES that while not disclosed, Arena has been hiding that Japan was also unwilling to approve Belviq. -sv (Remember: I am dedicated to DD, so study the 10K. It looks like Japan told Eisai, 'No to Belviq' and it's being hidden from retail investors.)
Interesting that Switzerland allows manufacturing of the drug in a plant in their country that is exported from their country, but it not approved in their country. Now we know the USA does not allow unapproved drugs to come into the country, so FDA must have gone there and approved the plant for importation.
This stall in improving ARNA drugs just shows the fear of the other drugs companies. The ARNA pipeline will destroy the use of other drugs unless those drugs can be used with ARNA drugs. Case in point: Bel-Phen. Case in point: Opiate pain killers. Case in point: Diabetic use. Case in point: High blood pressure reduction. That is just some of the potential uses of ARNA drugs. The other drugs companies will have to joint with ARNA or become obsolete.
Think investors. Why was Eisai OBLIGATED to talk to Japan AFTER first going back to the EU EMA? -sv (Arena's Jack Lief has a nasty habit of hiding SEC file-able information from retail investors. I'll just about bet that this little tidbit went over the head of the hedge funds.)